marijuana stocks news

Cannabis Sativa, Inc. (CBDS)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014
Total Revenue 1   4   1   0  
Cost of Revenue 1 0 0 1
Gross Profit (0) 4   1   (1)
Operating Expenses
Research Development – 4 – –
Selling General and Administrative 1,780 987 171 100
Non Recurring – 13,070 – –
Others – – – –
Total Operating Expenses – – – –
Operating Income or Loss (1,780) (14,057) (170) (101)
Income from Continuing Operations
Total Other Income/Expenses Net – 90 (40) –
Earnings Before Interest And Taxes (1,780) (13,968) (210) (101)
Interest Expense 8 8 6 4
Income Before Tax (1,788) (13,975) (216) (104)
Income Tax Expense – – – –
Minority Interest – – – –
Net Income From Continuing Ops (1,788) (13,975) (216) (104)
Non-recurring Events
Discontinued Operations – – – –
Extraordinary Items – – – –
Effect Of Accounting Changes – – – –
Other Items – – – –
Net Income (1,788) (13,975) (216) (104)
Preferred Stock And Other Adjustments – – – –
Net Income Applicable To Common Shares (1,788) (13,975) (216) (104)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Cresco Labs Inc. (CRLBF) Closes New Senior Secured Credit Facility with Existing Lenders

Cresco Labs Closes New Senior Secured Credit Facility with Existing Lenders Cresco…

$GWPH Officially to NASDAQ Biotechnology Index

GW Pharmaceuticals Added to NASDAQ Biotechnology Index LONDON, Dec. 22, 2014 (GLOBE…

$PMCB Discusses Protection Strategy for Cancer and Diabetes Therapies

PharmaCyte Biotech Discusses Protection Strategy for Cancer and Diabetes Therapies PharmaCyte Biotech,…

 CLS Holdings USA, Inc. (CLSH) Announces April, May and June Financial Results

CLS Holdings Announces April, May and June Financial Results, Is on Track…